You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR BONTRIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BONTRIL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02233647 ↗ Phendimetrazine and Cocaine Completed National Institute on Drug Abuse (NIDA) Early Phase 1 2014-09-01 This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
NCT02233647 ↗ Phendimetrazine and Cocaine Completed University of Kentucky Early Phase 1 2014-09-01 This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
NCT02233647 ↗ Phendimetrazine and Cocaine Completed William Stoops Early Phase 1 2014-09-01 This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
NCT02522325 ↗ Reinforcing Effects of Cocaine During Phendimetrazine Maintenance Completed National Institute on Drug Abuse (NIDA) Phase 1 2015-08-01 This study will determine the initial efficacy of phendimetrazine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
NCT02522325 ↗ Reinforcing Effects of Cocaine During Phendimetrazine Maintenance Completed University of Kentucky Phase 1 2015-08-01 This study will determine the initial efficacy of phendimetrazine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
NCT02522325 ↗ Reinforcing Effects of Cocaine During Phendimetrazine Maintenance Completed William Stoops Phase 1 2015-08-01 This study will determine the initial efficacy of phendimetrazine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BONTRIL

Condition Name

Condition Name for BONTRIL
Intervention Trials
Cocaine Use Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BONTRIL
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BONTRIL

Trials by Country

Trials by Country for BONTRIL
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BONTRIL
Location Trials
Kentucky 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BONTRIL

Clinical Trial Phase

Clinical Trial Phase for BONTRIL
Clinical Trial Phase Trials
Phase 1 1
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BONTRIL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BONTRIL

Sponsor Name

Sponsor Name for BONTRIL
Sponsor Trials
National Institute on Drug Abuse (NIDA) 2
University of Kentucky 2
William Stoops 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BONTRIL
Sponsor Trials
Other 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.